Top Markets
Coin of the day
Zymeworks Inc. Zymeworks Inc.

Zymeworks Inc.

ZYME
Pozycja w akcjach #6233
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase,... Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract, gastroesophageal region (adenocarcinomas), breast, and colon; and ZW49, an antibody-drug conjugate targeting two sites on the human epidermal growth factor receptor 2 (HER2), which is in Phase 1 trials for advanced or spreading tumors that express HER2. Zymeworks maintains significant alliances with several pharmaceutical leaders, including Merck Sharp & Dohme Research Ltd., Eli Lilly and Company, Bristol-Myers Squibb company, GlaxoSmithKline Intellectual Property Development Ltd., Daiichi Sankyo Co., Ltd., Janssen Biotech, Inc., BeiGene, Ltd., and Exelixis, Inc. Furthermore, it engages in cooperative research and licensing agreements with LEO Pharma A/S, specifically for the exploration, advancement, and market introduction of bispecific antibodies, and with Iconic Therapeutics, Inc. Established in 2003, Zymeworks Inc. operates from its headquarters located in Vancouver, Canada.
Cena akcji
$29.33
Kapitalizacja rynkowa
$2.16B
Zmiana (1 dzień)
0.07%
Zmiana (1 rok)
96.42%
Kraj
US
Handel Zymeworks Inc. (ZYME)

Kategoria

Historia ceny akcji dla Zymeworks Inc. (ZYME)
Najwyższa cena zamknięcia: $26.22 dnia 2026-08-01

Najniższa cena zamknięcia: $13.00 dnia 2017-04-01
Historia cen akcji firmy Zymeworks Inc. od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -12.16%
2025 90.41%
2024 44.87%
2023 30.92%
2022 -56.92%
2021 -67.45%
2020 19.67%
2019 233.57%
2018 63.85%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$548.48 40.97%
US
$1.06K 49.38%
NL
$122.63 -12.65%
AU
$140.50 459.76%
US
$765.25 7.19%
CH